Home Biosimilar Antibodies Others Others antibody Codrituzumab (Anti-GPC3 / Glypican-3) For research use only.
Not for use in humans.

Codrituzumab (Anti-GPC3 / Glypican-3)

Synonyms: GC33; RO5137382

Codrituzumab is a monoclonal antibody targeting GPC3 (glypican-3) which is an oncofetal protein expressed on the cell surface of hepatocellular carcinoma (HCC). Codrituzumab induces antibody-dependent cellular cytotoxicity (ADCC) and inhibits tumor growth. MW: 150 KD.

Codrituzumab (Anti-GPC3 / Glypican-3)

Purity & Quality Control

≥99

Biological Activity

Description Codrituzumab is a monoclonal antibody targeting GPC3 (glypican-3) which is an oncofetal protein expressed on the cell surface of hepatocellular carcinoma (HCC). Codrituzumab induces antibody-dependent cellular cytotoxicity (ADCC) and inhibits tumor growth. MW: 150 KD.

Product Details

CAS No. 1365267-33-9
Molecular Weight 150 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Codrituzumab (Anti-GPC3 / Glypican-3) | Codrituzumab (Anti-GPC3 / Glypican-3) supplier | purchase Codrituzumab (Anti-GPC3 / Glypican-3) | Codrituzumab (Anti-GPC3 / Glypican-3) cost | Codrituzumab (Anti-GPC3 / Glypican-3) manufacturer | order Codrituzumab (Anti-GPC3 / Glypican-3) | Codrituzumab (Anti-GPC3 / Glypican-3) distributor